JMJason Manassa

Jason Manassa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jason Manassa has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • E-mode AlGaN/GaN HEMT with ScAlN/ScN charge trap-coupled ferroelectric gate stacks

    by Jiangnan Liu, Ding Wang, Tanvir Hasan, Shubham Mondal, Jason Manassa, Jeremy M. Shen, Danhao Wang, Mehedi Hasan Tanim, Samuel Yang, Robert Hovden, et al.

    A fully epitaxial ferroelectric ScAlN/AlGaN/GaN HEMT coupled with an ultrathin ScN charge trap layer for enhancement-mode operation is demonstrated. The ultrathin ScN acts as an electron reservoir to trap and store the electrons from the 2-dimensional electron gas channel region, transitioning the operation of the GaN high electron mobility transistor from the depletion-mode to the enhancement-mode, while the fully epitaxial nature enables low interface defect density and steep slope operation. The initialization process by applying a positive gate bias to inject carriers to the ScN layer is observed to shift the threshold voltage (Vth) from −1.2 to +1.3 V. The fabricated device also shows a steep subthreshold swing as low as 61 mV/dec and exhibits good stability, providing a promising pathway for power-efficient and multifunctional applications.


  • Open Access

    An Unexpected Source of Hard Carbon, Rice Hull Ash, Provides Unexpected Li + Storage Capacities

    by Mengjie Yu, Man Wang, Sylvio Indris, Jason Manassa, Alex Stangel, Robert Hovden, Richard M. Laine

    Hard carbon (HC) anodes used in secondary batteries have attracted increasing recent attention in particular to transition to new energy storage formats. To date, HC is produced exclusively by charring organic precursors in inert atmospheres. One would not expect to find HC in rice hull ash (RHA), the byproduct of rice hull combustion processes. However, in developing approaches to depolymerize RHA SiO 2 (90:10 wt% SiO 2 :C) to produce silica‐depleted RHA or SDRHA 40‐60 (40–60 wt% SiO 2 ) to tailor C:SiO 2 ratios for carbothermal reduction reactions, the SDRHA carbon component is recently revisited. In more detailed efforts to characterize the form of carbon present in SDRHA, a series of analyses reveal graphitized carbon domains in amorphous matrices, i.e., HC, despite RHA being produced via combustion in an oxidizing atmosphere. Comprehensive electrochemical analyses on SDRHA 40‐60 find unexpected capacities far in excess (>700 mAh g −1 ) of reported values for HC and graphite. Electrochemical and STEM characterization suggest that the unexpected capacity may come from the nanoscale morphology of the amorphous carbon component. Given that RHA is a biowaste generated in kilotons/year worldwide, there seems to be an opportunity to develop sustainable high‐capacity anode materials for alkali‐ion storage systems.


  • Open Access

    Fused Multi-Modal Electron Microscopy

    by Jason Manassa, Miti Shah, Min Gee Cho, Zichao Wendy Di, Yi Jiang, Jeffrey A. Fessler, Yu-Tsun Shao, Mary C. Scott, Jonathan Schwartz, Robert Hovden

    Chemical mapping of nano-scale and atomic chemistry via spectroscopic electron microscopy has challenged researchers for decades due to the fundamental tradeoff between electron dose, noise, and resolution. Inelastic spectroscopic signals (electron energy loss (EELS) or energy-dispersive x-ray (X-EDS) spectroscopy) that yield elemental signatures are rare, resulting in long dwell times to produce discernable structure. This process often destroys the sample and distorts the chemical map during acquisition.Lower dose scans can be taken to combat this issue, but they often do not have enough signal to produce meaningful results.Fused multi-modal electron microscopy offers nano- and atomic-resolution high signal-to-noise-ratio (SNR) recovery of material chemistry by merging low-dose elastically scattered high-angle annular dark-field (HAADF) signals with the inelastic signals. The process works best when all chemistries in the material are mapped spectroscopically and combined with a directly interpretable elastic signal. This article bridges the gap between theory and practice by walking through each step of the fused multi-modal computational pipeline and pointing out best practices when running the code. By the end of this tutorial, anyone with inelastic and elastic 2D projection data should be able to reproducibly reconstruct chemical maps using fused multi-modal electron microscopy.

  • Open Access

    Imaging 3D chemistry at 1 nm resolution with fused multi-modal electron tomography

    by Jonathan Schwartz, Zichao Wendy Di, Yi Jiang, Jason Manassa, Jacob Pietryga, Yiwen Qian, Min Gee Cho, Jonathan L. Rowell, Huihuo Zheng, Richard D. Robinson, et al.

    Measuring the three-dimensional (3D) distribution of chemistry in nanoscale matter is a longstanding challenge for metrological science. The inelastic scattering events required for 3D chemical imaging are too rare, requiring high beam exposure that destroys the specimen before an experiment is completed. Even larger doses are required to achieve high resolution. Thus, chemical mapping in 3D has been unachievable except at lower resolution with the most radiation-hard materials. Here, high-resolution 3D chemical imaging is achieved near or below one-nanometer resolution in an Au-Fe3O4 metamaterial within an organic ligand matrix, Co3O4-Mn3O4 core-shell nanocrystals, and ZnS-Cu0.64S0.36 nanomaterial using fused multi-modal electron tomography. Multi-modal data fusion enables high-resolution chemical tomography often with 99% less dose by linking information encoded within both elastic (HAADF) and inelastic (EDX/EELS) signals. We thus demonstrate that sub-nanometer 3D resolution of chemistry is measurable for a broad class of geometrically and compositionally complex materials.


  • Open Access

    Supplemental Table S2 from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Supplemental Table S2. Antibody panel used for CyTOF analysis.

  • Open Access

    Supplemental Table S1 from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Supplemental Table S1. Stains and antibodies used for mIHC.

  • Open Access

    Supplemental Figure S3 from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Supplemental Figure S3. PCA biplot (PC1 and PC2) of VST-normalized gene counts for the top 500 most variable genes.

  • Open Access

    Supplemental Figure S2 from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Supplemental Figure S2. Expression of immune cell surface markers by CyTOF.

  • Open Access

    Data from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Idiopathic pulmonary fibrosis (IPF) is characterized by progressive, often fatal loss of lung function due to overactive collagen production and tissue scarring. Patients with IPF have a sevenfold-increased risk of developing lung cancer. The COVID-19 pandemic has increased the number of patients with lung diseases, and infection can worsen prognoses for those with chronic lung diseases and disease-associated cancer. Understanding the molecular pathogenesis of IPF-associated lung cancer is imperative for identifying diagnostic biomarkers and targeted therapies that will facilitate prevention of IPF and progression to lung cancer. To understand how IPF-associated fibroblast activation, matrix remodeling, epithelial-to-mesenchymal transition (EMT), and immune modulation influences lung cancer predisposition, we developed a mouse model to recapitulate the molecular pathogenesis of pulmonary fibrosis–associated lung cancer using the bleomycin and Lewis lung carcinoma models. We demonstrate that development of pulmonary fibrosis–associated lung cancer is likely linked to increased abundance of tumor-associated macrophages and a unique gene signature that supports an immune-suppressive microenvironment through secreted factors. Not surprisingly, preexisting fibrosis provides a pre-metastatic niche and results in augmented tumor growth, and tumors associated with bleomycin-induced fibrosis are characterized by a dramatic loss of cytokeratin expression, indicative of EMT.Implications:This characterization of tumors associated with lung diseases provides new therapeutic targets that may aid in the development of treatment paradigms for lung cancer patients with preexisting pulmonary diseases.

  • Open Access

    Supplemental Table S1 from Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

    by Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, et al.

    Supplemental Table S1. Stains and antibodies used for mIHC.